Geneia’s population health consultants are nurses who work with health plans, provider practices and employer groups to identify opportunities to engage patients at the individual and population levels to improve cost, utilization and risk.
Let’s start with an example.
One of Geneia’s seven population health consultants, Mary Elizabeth Myers, RN, BSN, works with the Lehigh Valley Business Coalition on Healthcare (LVCBH), a multi-state, not-for-profit coalition of employers striving to provide access to quality affordable healthcare for their employees. She’s assigned to the Geneia LVBCH Data Group, a subset of the coalition’s employers who use the Theon® Platform to access and act on population insights, such as trends in emergency department utilization and primary care usage.
In August, Mary Elizabeth, in collaboration with the Geneia team that works with LVBCH – Laura Syron, manager, client executive team, Keyi Shi, clinical outcomes informatics specialist, and me – reviewed with the LVBCH Data Group how the pandemic has impacted utilization and health outcomes as well as identification of employer considerations.
As has been widely reported, national healthcare utilization has declined precipitously during the COVID-19 pandemic. Utilization decreases for the Geneia LVBCH Data Group mirror the national findings.
Hidden health concerns are beginning to emerge at the national level including significant declines in breast, cervical and colon cancer screenings and substantial increases in employee stress and mental health prescriptions. An American Journal of Managed Care article reported 69 percent of employees say the COVID-19 pandemic is the most stressful time in their entire career. At the same time, there has been a 21 percent increase in the weekly fill for antidepressant, antianxiety and anti-insomnia medications, and 78 percent of those filled were new prescriptions, demonstrating the serious impact that COVID-19 is having on our nation’s mental health.
As we discussed with LVBCH employers, there is an opportunity for human resource and benefits leaders to help employees through this time by addressing stress, anxiety and other concerns. The recommendations include focusing on benefits that address stress, including mental health benefits, employee assistance programs and financial wellness programs. Experts also say regular communication about employers’ response to the coronavirus and educating employees on benefits that are available to assist them are also helpful.
To watch two Geneia - LVBCH webinars, COVID-19 Impact on Utilization and Health Outcomes and COVID-19 Impact on Mental Health and Substance Abuse, visit: http://lvbch.com/.
To learn more about how Geneia works with employers in the LVBCH data group, I encourage you to read the City of Allentown client success story by clicking here.
Population Health Consultants Work with Health Plans, Employers and Value-Based Providers
In addition to the work with LVBCH, our seven population health consultants (PHC ) work with 164,000 health plan members across nine employer groups and one value-based care provider organization.
- Identify: The PHCs mine data in the Theon® platform and utilize Geneia Data Intelligence Lab models for patient identification such as the COVID-19 one which answers the question – Given that a patient was to test positive, what is that person’s risk for developing severely adverse health outcomes, such as hospitalization?
- Analyze: The PHCs review cost, utilization and risk data, evaluate trends and patterns, and identify opportunities.
- Refer: The PHCs refer patients to Geneia case management, provide feedback to clients and recommend population-level improvement strategies and insights.
Without a doubt, Geneia PHCs have diverse set of clients and assignments, from working with the LVBCH Data Group employers to performing a gap analysis for a health plan, helping another payer engage their provider partners and consulting on reporting requirements for a provider practice. Yet, their mission to help health plans, provider practices and employer groups identify and engage patients and populations to improve cost, utilization and risk remains consistent.